Cargando…
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
CTLA-4, initially described as a membranebound molecule, is a costimulatory receptor transducing a potent inhibitory signal. Increasing evidence shows the CTLA-4 gene to be an important susceptibility locus for autoimmune endocrinopathies and other autoimmune disorders. A soluble form of cytotoxic T...
Autores principales: | Saverino, Daniele, Simone, Rita, Bagnasco, Marcello, Pesce, Giampaola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389044/ https://www.ncbi.nlm.nih.gov/pubmed/26000110 http://dx.doi.org/10.1007/s13317-010-0011-7 |
Ejemplares similares
-
The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses
por: Simone, Rita, et al.
Publicado: (2014) -
A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d(+) Expression
por: Simone, Rita, et al.
Publicado: (2012) -
Serum LAIR-2 Is Increased in Autoimmune Thyroid Diseases
por: Simone, Rita, et al.
Publicado: (2013) -
High Levels of Soluble Ctla-4 Are Present in Anti-Mitochondrial Antibody Positive, but Not in Antibody Negative Patients with Primary Biliary Cirrhosis
por: Saverino, Daniele, et al.
Publicado: (2014) -
92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
por: Riccio, Anna Maria, et al.
Publicado: (2012)